Novozymes A S DKK 2.0
13F holders, Q2 2024 (June 30)5holders
0new positions
0sold out
$61.02avg. 13F price*
At the end of Q2 2024, 5 institutions reported holding Novozymes A S DKK 2.0 in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were Somerville Kurt F ($1.4M), Broderick Brian C ($824K) and Kidder Stephen W ($438K).
- Company
- Novozymes A S DKK 2.0
- CUSIP
- B798FW902
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 8,975 shares sold, net −8,975 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Somerville Kurt F | 0.23% | No change | 22,840 | $1.4M |
| Broderick Brian C | 0.17% | Reduce -29.9% | 13,509 | $824K |
| Kidder Stephen W | 0.14% | Reduce -7.4% | 7,175 | $438K |
| Hemenway Trust Co LLC | 0.03% | Reduce -6.8% | 5,521 | $337K |
| Puzo Michael J | 0.08% | Reduce -32.0% | 4,775 | $291K |
"% of holder's portfolio" is NOVOZYMES A S DKK 2.0's weight in each manager's 13F, not the share of Novozymes A S DKK 2.0 the manager owns.